Skip to main content

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

Include preview-only content
  1. Article

    Open Access

    Evaluation of [ 13 N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brain

    The conversion of synaptic glutamate to glutamine in astrocytes by glutamine synthetase (GS) is critical to maintaining healthy brain activity and may be disrupted in several brain disorders. As the GS catalys...

    Alice Egerton, Joel T. Dunn, Nisha Singh, Zilin Yu, Jim O’Doherty in EJNMMI Research (2020)

  2. Article

    Open Access

    Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma

    Metabolic tumour volume (MTV) is a promising prognostic indicator in diffuse large B cell lymphoma (DLBCL). Optimal thresholds to divide patients into ‘low’ versus ‘high’ MTV groups depend on clinical characte...

    Hajira Ilyas, N. George Mikhaeel in European Journal of Nuclear Medicine and M… (2018)

  3. Article

    Open Access

    Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL

    The study objectives were to assess the prognostic value of quantitative PET and to test whether combining baseline metabolic tumour burden with early PET response could improve predictive power in DLBCL.

    N. George Mikhaeel, Daniel Smith in European Journal of Nuclear Medicine and M… (2016)

  4. Article

    Open Access

    Assessing radiotracer kinetics in the Langendorff perfused heart

    The Langendorff perfused heart is a physiologically relevant and controllable model with potential for assessing the pharmacokinetics of new radiotracers under a range of pathophysiological conditions.. We ass...

    Erika Mariotti, Mattia Veronese, Joel T Dunn, Rodolfo A Medina in EJNMMI Research (2013)